| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
AR
|
androgen receptor
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ATF3
|
activating transcription factor 3
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CA9
|
carbonic anhydrase IX
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CDC37
|
cell division cycle 37
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CLDN4
|
claudin 4
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYTL1
|
cytokine-like 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
EDN1
|
endothelin 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FGF17
|
fibroblast growth factor 17
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FOXP3
|
forkhead box P3
|
|
GRP
|
gastrin-releasing peptide
|
|
GTF2H2
|
general transcription factor IIH, polypeptide 2, 44kDa
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
IFI44
|
interferon-induced protein 44
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL21R
|
interleukin 21 receptor
|
|
KDR
|
kinase insert domain receptor
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
LEPR
|
leptin receptor
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LOX
|
lysyl oxidase
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MT3
|
metallothionein 3
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
NFIB
|
nuclear factor I/B
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PON1
|
paraoxonase 1
|
|
PRL
|
prolactin
|
|
PROS1
|
protein S (alpha)
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR4
|
toll-like receptor 4
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TYMS
|
thymidylate synthetase
|
|
UMPS
|
uridine monophosphate synthetase
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWCE
|
von Willebrand factor C and EGF domains
|
|
WDR77
|
WD repeat domain 77
|
